Integrated Biopharma Inc Q1 FY2024 Earnings Call

Integrated Biopharma Inc (INBP)

Earnings Call FY2024 Q1 Call date: 2023-11-09 Concluded

Quarter scorecard

Revenue

$12.91M

+4.8% YoY

Gross margin

6.4%

-1.7 pp YoY

Net income

Contract Manufacturing $12.44M

+7.6%

Other Nutraceutical Business $478,000

-37.5%